Start with intended use, market and regulatory boundary
The first RFQ mistake is asking a textile supplier to make the regulatory determination. ISO 10993 is a biological-evaluation framework, not a one-line blanket certificate. The legal manufacturer of the final product, system or kit decides whether the blanket is a medical device, an accessory, a kit component, or a general-use textile in each target market, then defines the biological evaluation plan and any required testing. The textile mill supplies material, process and traceability inputs that support that work.
Do not imply that inclusion in a kit automatically changes legal status. A blanket packed into a transport set, admission pack or emergency kit may still need a market-specific classification analysis. Hospital procurement rules are also separate from device law. A hospital may require restricted-substance declarations, laundering data, AQL inspection, or cleaner packaging even where the article is not regulated as a device. Keep those two layers distinct in the RFQ: regulatory obligations versus customer procurement requirements.
For patient transport programmes, some blankets are assessed as surface-contacting, intact-skin-contact articles, but that is not a safe default. The evaluation can change if the blanket is marketed with a warming or therapeutic claim, used in neonatal or sensitive-patient settings, positioned against compromised skin, secured around lines or dressings, integrated with straps or accessory hardware, or placed where prolonged wet or occluded contact is expected. Those scenarios usually need a stricter review than a simple cover blanket used for short transport intervals.
Write these fields into the RFQ before asking for any ISO 10993 inputs: target market; legal manufacturer; intended use statement; whether the article is sold standalone or packed in a kit; claimed function; contacting tissue type; expected duration band; single-use, single-patient-use or reusable status; sterile or non-sterile supply status; and whether contact with compromised skin is expected or prohibited. Without that, the mill can quote only a textile article, not a compliance-ready document package.
If your need is operational rather than regulated, a simpler benchmark is a relief-grade fleece such as 180gsm polyester fleece blankets with overlocked edges for disaster relief. Patient transport programmes usually need tighter change control, packaging discipline and lot-level traceability than open-stock relief blankets.
Build a revision-controlled BOM that procurement can audit
A purchase spec that says only '180gsm polyester fleece, 130 x 170cm, navy' is not enough. The buyer should request a revision-controlled BOM covering all materials that contact the blanket directly or could transfer residues to it during manufacture or primary packing. At minimum, each BOM line should show revision level, effective date, internal material code, supplier name, manufacturing site, country of origin, unit of measure, usage rate, and change-control owner. A signed BOM without those fields is weak for medical or healthcare sourcing.
For this product, the BOM usually needs separate lines for base fleece fabric, sewing thread, edge finish construction, woven or printed care label, label ink or transfer chemistry, individual bag film, bag closure system, carton liner if used, and any intentionally added finish such as softener, antistatic, water-repellent or antimicrobial treatment. If there is no added finish, state 'none intentionally applied after dyeing/finishing except standard process auxiliaries' only if that statement is accurate and controlled.
For a lower-risk first article, many buyers simplify the construction: 100% polyester knitted fleece, typically based on 75D/144F to 100D/144F polyester filament; plain-dyed or undyed; no print; no fragrance; no antimicrobial claim; overlocked edge or simple folded hem; and clear LDPE or PP individual bag without colour masterbatch. Those are buyer choices to reduce variables, not universal rules. The mill should confirm actual yarn route, brushing/shearing construction and achievable control range on the production line.
Where you need purchase targets, write them as measurable tolerances. Common commercial starting points for this category are finished mass per unit area 180gsm ±5% tested to ISO 3801 or equivalent agreed cut-and-weigh method; cut size 130 x 170cm ±2cm before wash; and finished dimensions conditioned for at least 4 hours at 20 ±2°C and 65 ±4% RH in line with ISO 139 before measurement. If dimensional stability matters after laundering, name the exact method rather than saying 'low shrinkage'.
Ask for component origin by line item, not just final assembly origin. For example: greige knit origin, dyeing/finishing site, thread supplier and site, label converter, bag-film extruder/converter, and final cut-sew-pack site. This level of detail is standard for traceability; it is far more useful than broad statements such as 'made in China'.
Ask for the right document package: commonly obtainable versus limited
Buyers often mix sensible requests with unrealistic ones. A textile mill can commonly provide: BOM; TDS for fabric, thread and pack film; process flow; certificate of conformity or certificate of analysis format; country of origin declarations; fibre composition declaration; care-label proposal; incoming and final QC records; and declarations for intentionally added finishes where the upstream supplier releases them. These are normal RFQ asks.
Requests that are often limited or unrealistic at mill level include full CAS-level disclosure for every upstream formulation component, confidential dyehouse recipes, 100% extractables/leachables packages, or unrestricted access to all sub-supplier chemistry. Some upstream suppliers will disclose only formulation family, functional class, or a restricted-substance compliance statement. If you need deeper chemistry, route that need through the legal manufacturer's toxicologist and test lab so the request is targeted and defensible.
For biological evaluation support, ask for a supplier input package, not a universal declaration that the blanket 'is ISO 10993 compliant'. A workable package usually includes: revision-controlled BOM; TDS for each line item; SDS or equivalent safety information for intentionally added finishes where available; declaration of intentionally added substances; packaging resin and thickness specification; lot coding logic; representative production samples; and change history for major components and sites.
Use ISO 10993-1, ISO 10993-18 and ISO 10993-17 accurately. Under the current ISO 10993 framework, endpoint selection does not come only from contact category and exposure duration. It comes from the biological evaluation plan built under risk management, considering the nature of body contact, duration, material composition, manufacturing residues, clinical context, prior knowledge and any changes from previously assessed materials. Supplier data may support chemical characterisation under ISO 10993-18, toxicological risk assessment under ISO 10993-17, and the overall biological evaluation under ISO 10993-1.
Chemical characterisation also does not mean every component must always be tested in isolation. A defensible strategy may combine supplier disclosure, prior data, literature, toxicology review and targeted analytical work on the finished article or selected high-risk components. Finished-article work is more likely where there are dark shades, multiple finishes, prints, recycled inputs with variable upstream control, prolonged contact, sensitive-patient use, weak upstream disclosure, or a change that could alter the chemical profile.
Sterilisation, non-sterile supply and packaging control are separate decisions
Most polyester transport blankets are supplied non-sterile. If sterile supply is required, do not treat sterilisation as a footnote. The RFQ must separately define the sterilisation route such as EO or gamma, the sterile barrier or protective packaging design, pre-sterilisation cleanliness expectations, sampling plan, and post-sterilisation acceptance criteria. Textile suitability and packaging suitability both need validation.
For EO, buyers usually need validation not only of textile appearance and strength but also of EO residuals, odour, colour shift, brittleness, seam performance and seal integrity after the validated cycle and aging protocol. For gamma or e-beam, watch for yellowing, loss of softness, film embrittlement, label-legibility changes, adhesive failure, and seal degradation. A fleece that passes pre-sterile handling can still fail after irradiation or sterilant exposure.
For non-sterile blankets, distinguish primary pack contact materials from secondary transit materials. The primary pack spec should name the film resin such as LDPE, HDPE, PP or coextruded structure; nominal film thickness, often around 40 to 70 microns for a simple single blanket bag; closure system such as heat seal, adhesive flap or zip; cleanliness expectation; and whether the bag is merely protective or part of a controlled-cleanliness system. If there is a sterile barrier, call it out separately; do not hide it inside a generic 'polybag' line item.
Bag specification matters because contact transfer can occur from slip additives, inks, odour or sealing defects. If the bag touches the blanket directly, ask for resin identification, film gauge tolerance, seal width target, and print location so the printed area does not rub against the product face unless approved. For a basic non-sterile pack, a practical starting point is clear virgin LDPE or CPP bag, 50 ±10 microns, three-side or back seal, with no direct-contact printed patch over the folded product face, subject to the buyer's packaging system. Related construction trade-offs are covered in picnic blanket backing PEVA PU TPU for outdoor goods; the same sourcing discipline applies even though the end use here is different.
Make QC measurable: test methods, tolerances and AQL rules
A healthcare RFQ should state acceptance criteria, test method and sampling basis. If you leave QC at 'good quality' or 'clean appearance', every dispute moves to opinion. At minimum, define release checks for mass, dimensions, visual defects, seam integrity, shade, foreign matter, pack seal and carton marking. Use a standard inspection level such as ANSI/ASQ Z1.4 or ISO 2859-1, General Inspection Level II; many buyers use AQL 2.5 for major defects and AQL 4.0 for minor defects, while medical or high-visibility programmes may tighten that further.
A practical QC schedule for a 180gsm polyester fleece transport blanket can read as follows: mass per unit area to ISO 3801, average lot result within 180gsm ±5%; dimensions measured after conditioning to ISO 139, each sampled unit within 130 x 170cm ±2cm; seam security by seam slippage or seam strength method agreed by buyer, for example a minimum seam tensile target developed with reference to ASTM D5034 seam strength targets where relevant to construction; shade against approved standard under D65 or TL84 lighting with tolerance stated by the buyer, commonly grey scale 4 minimum for lot continuity or a defined instrumental delta if both parties use spectro data.
Visual defect criteria should be explicit. Suggested major defects: hole, cut, open seam, missing label, wrong size beyond tolerance, wrong colour family, visible oil mark over 5mm, rust mark, broken seal, foreign contamination, or incorrect lot code. Suggested minor defects: loose thread over 30mm not affecting function, slight brushing streak away from the display face, or edge waviness within buyer tolerance. If the article is individually packed for healthcare use, many buyers treat any hair, insect fragment, glass, metal fragment or hard contamination as critical and reject the lot regardless of AQL count.
For foreign matter and cleanliness, define the inspection environment: 1000 to 1500 lux neutral white lighting, clean table, operator gloves if required, and inspection distance of about 50cm. Acceptance can read: no visible hair, insect contamination, hard particles, oil staining, rust staining, mildew marks or contrasting foreign fibres on exposed faces. For loose lint, write a visual or tape-lift method if needed rather than vague 'low lint'.
Packaging checks should include film type, thickness, seal continuity, seal width, no open channels or splits, correct count, correct label content and lot-code readability. A simple seal check can require no burst-open edge under manual peel at corners plus no visible channel along the seal line. If you want a quantified seal-strength target, name the method and target explicitly rather than asking for 'strong seal'. Buyers who need a fuller incoming and pre-shipment template can cross-check with blanket quality control inspection and AQL 2.5 inspection checklist for fleece blankets.
Conditioning, wash testing and shade retention: name the method
The article spec should not say 'after washing, no obvious shrinkage'. Name the method. For conditioning before measurement, a common textile baseline is ISO 139 at 20 ±2°C and 65 ±4% RH. For dimensional change after domestic laundering, many buyers use ISO 5077 with the chosen wash/dry procedure defined in the protocol; if a regional retail or hospital standard overrides this, state that method instead.
For reusable transport blankets, define wash cycles and appearance criteria. A practical starting point might be 5 wash cycles at 40°C for a light-duty single-patient reusable model or 10 to 25 cycles if the hospital programme expects repeated laundering. Then state pass/fail criteria for dimensional change, pilling, shade change, seam integrity and label legibility. If pilling matters, name the method and rating scale rather than simply saying 'anti-pilling'; related test expectations are discussed in anti-pilling test requirements for fleece blankets.
If the blanket is dark navy, black or red, include colourfastness requirements suited to the use case. Typical references are ISO 105-C06 for wash fastness, ISO 105-X12 for rubbing fastness, and where outdoor storage or UV exposure matters, ISO 105-B02. Do not copy test numbers without agreeing on the grade required. For healthcare transport blankets, many buyers target at least grade 4 colour change and grade 3-4 staining after the specified wash method, but the exact threshold should match the programme risk and shade difficulty.
Care labeling should also be aligned early. If you need ISO-style care symbols, say so and reference ISO 3758 care labeling guidance as a format reference, even though the actual content must match this blanket's material and wash route.
Traceability, record retention and change notification
Lot traceability should link every shipped unit or shipper carton back to the production record. At minimum, expect traceability fields for fabric lot, dye lot, brushing/shearing batch where used, sewing-thread lot, label lot, packaging film lot, production date, production line or site, inspector or release batch number, and finished goods lot code. If the programme is regulated or audit-heavy, ask how those fields appear on carton labels, internal travelers and ERP records.
Record retention should be stated instead of assumed. A practical commercial requirement is retain production, inspection and lot-linkage records for at least 2 years after shipment; healthcare programmes often ask for 5 years or more, especially where kits, complaints or recalls can run long. If your legal manufacturer needs a longer retention period, put the exact duration into the supply agreement.
Change notification terms should list both notice period and trigger events. A workable starting point is 90 days' advance written notice for planned changes and immediate notice for unplanned critical deviations. Trigger events should include resin change in primary packaging film, dyehouse transfer, yarn-source change, new finish chemistry or softener, label-ink change, thread supplier change, site transfer, process-range change affecting residues or appearance, and packaging film substitution due to shortage.
If a change affects biological evaluation, pack integrity, cleanliness, dimensions, laundering performance or product claims, the rule should be simple: do not ship against the old approval until the buyer or legal manufacturer completes review and re-approval. That escalation path prevents a common sourcing failure where a supplier treats a chemistry or site change as 'equivalent' without buyer sign-off. Buyers managing recycled-content programmes already use similar discipline in rPET fleece certification and documentation workflows.
Copy-ready RFQ checklist: ask this, not that
Use this short matrix to keep requests realistic. Ask the mill for: revision-controlled BOM; TDS for fleece, thread, label and bag; origin by component; process flow; lot coding logic; CoC/CoA format; inspection plan; representative production samples; and declarations on intentionally added finishes where available. Do not expect the mill alone to decide: market classification, final biological endpoints, toxicological risk conclusion, or whether the finished product is legally compliant in every jurisdiction.
Ask the legal manufacturer or test lab for: biological evaluation plan under ISO 10993-1; endpoint selection and rationale; need for ISO 10993-18 chemical characterisation; toxicological assessment under ISO 10993-17; sterilisation validation strategy; shelf-life or aging protocol; and complaint-handling thresholds. Do not ask the mill for: a generic 'ISO 10993 certificate' without defining the product, market, contact profile and change state.
A copy-ready RFQ line set can be: Material 100% polyester fleece, 180gsm ±5%; Size 130 x 170cm ±2cm after conditioning to ISO 139; Edge 4-thread overlock or approved hem; Colour approved lab dip with agreed shade tolerance; Primary pack clear virgin LDPE/CPP bag 50 ±10 microns, heat sealed; Inspection ISO 2859-1 or ANSI/ASQ Z1.4, GII, AQL 2.5 major / 4.0 minor unless otherwise stated; Cleanliness no visible foreign matter under 1000 to 1500 lux; Traceability lot linkage from fabric lot through packaging lot; Change control 90 days prior notice for listed triggers.
If you need a benchmark for lightweight travel and pack discipline outside healthcare, see specifying 180gsm microfleece travel blankets with nylon carry pouches. The end use is different, but the lesson is the same: the cleaner the material map and packaging spec, the fewer surprises at approval stage.
Buyer decision rule: if the supplier cannot provide a revision-controlled BOM, component-level origin, basic packaging specification, lot traceability fields and written change-notification terms, treat the source as not ready for a regulated or healthcare-sensitive blanket programme. Escalate either to a simpler non-regulated procurement route or to a supplier-development phase before placing production orders.
Frequently asked
Does putting a transport blanket inside a medical kit automatically make it a medical device? No. Kit inclusion alone does not settle legal status. The legal manufacturer needs a market-specific classification analysis covering intended use, claims, how the blanket functions in the system, and the target jurisdiction. Hospital procurement requirements can still be stricter than general retail sourcing even where the article is not regulated as a device.
Can a textile mill issue an 'ISO 10993 compliant' certificate for the blanket? A mill can usually provide input documents that support biological evaluation, such as BOM, TDS, finish declarations, process flow and traceability. The final biological evaluation and any compliance conclusion sit with the legal manufacturer, supported by toxicology and test-lab work where needed.
What ISO 10993 references are relevant for this kind of RFQ? Typically ISO 10993-1 for the biological evaluation framework, ISO 10993-18 for chemical characterisation inputs and ISO 10993-17 for toxicological risk assessment. Endpoint selection should come from the biological evaluation plan under risk management, not from contact category alone.
What can a supplier realistically disclose about chemistry? Commonly obtainable items are BOM, TDS, SDS or equivalent for intentionally added finishes where available, fibre composition, origin by component, process flow, and CoC or CoA format. Full CAS-level disclosure of every upstream formulation ingredient, confidential dye recipes or a full extractables package is often limited or unavailable at mill level unless managed through a targeted lab programme.
What QC criteria should be written into the PO or RFQ? State method, tolerance and sampling basis for mass, dimensions, visual defects, seam integrity, shade, foreign matter, packaging seal and labeling. A typical starting point is ISO 2859-1 or ANSI/ASQ Z1.4 General Inspection Level II with AQL 2.5 major and 4.0 minor, 180gsm ±5%, size tolerance ±2cm after ISO 139 conditioning, and explicit cleanliness and pack-seal criteria.
How should packaging be specified for non-sterile transport blankets? Name the primary contact material, nominal thickness, closure system, print location, cleanliness expectation and whether the bag is only protective or part of a controlled-cleanliness system. For simple non-sterile supply, buyers often start with a clear virgin LDPE or CPP bag around 50 microns with heat seal, but the approved packaging system should be tied to the programme risk and handling route.
What traceability fields should a buyer expect? At minimum: fabric lot, dye lot, finishing or brushing batch if relevant, sewing-thread lot, label lot, packaging-film lot, production date, line or site, finished lot code and shipment linkage. Record-retention duration should also be written into the supply agreement.
When should change notification trigger re-approval? Any change that could affect biological risk, cleanliness, packaging contact, dimensions, appearance, laundering performance or claims should trigger review before shipment. Typical triggers include yarn-source change, dyehouse transfer, finish chemistry change, label-ink change, primary-pack resin substitution, site transfer and process changes outside approved ranges.
Have a project in mind? Send us your spec — we'll reply within one business day with indicative pricing and a sample plan.